Clinical Trials
15 trialsNCT06455735 2024-06-12
68Ga-JH04 PET/CT in Patients With Various Types of Cancer
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT06321120 2024-03-20
Using Chronobiology to Improve Lenvatinib Efficacy
Hadassah Medical Organization
Phase EARLY_PHASE1 Unknown
NCT02469129 2023-12-12
PET Imaging of PARP Activity in Cancer
Washington University School of Medicine
Phase EARLY_PHASE1 Unknown
NCT06126705 2023-11-13
18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor
Affiliated Hospital of North Sichuan Medical College
Phase EARLY_PHASE1 Unknown
NCT05490849 2023-02-22
68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Unknown
NCT05691855 2023-01-20
89Zr-labeled NY009 PET Imaging in Patients
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Unknown
NCT05691881 2023-01-20
68Ga-labeled NY105 PET Imaging in Patients
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Unknown
NCT05691894 2023-01-20
Tracer Targeting FAP PET Imaging in Patients
Affiliated Hospital of Jiangnan University
Phase EARLY_PHASE1 Unknown
NCT04721756 2022-04-25
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
Avid Radiopharmaceuticals
Phase EARLY_PHASE1 Unknown
NCT04702841 2021-03-08
CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04691349 2021-01-11
CAR-T for r/r Malignant Tumors in Children
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04499365 2020-09-09
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT04525612 2020-09-09
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT04011293 2019-07-08
A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
Shandong University
Phase EARLY_PHASE1 Unknown
NCT01713218 2012-10-24
NEOPACHI-001
Erasme University Hospital
Phase EARLY_PHASE1 Unknown